Year | Title | City | Sponsor | Status |
---|---|---|---|---|
2010–2016 | Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection | Ho Chi Minh City, Hai Phong | University of Hawaii | Active, not recruiting |
2014–2016 | The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment’s Effects on Chronic Hepatitis C Patients | Unknown | Nanogen Pharmaceutical Biotechnology Co., Ltd | Completed |
2015–2016 | Feasibility of Interventions on People Who Inject Drugs in Vietnam |  |  |  |
Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities | Ho Chi Minh City, Hanoi | Inserm-ANRS | Completed | |
2013–2016 | HCV Treatment in HIV Co-Infected Patients in Asia | Hanoi | amfAR, | Completed |
2016 | Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients | Unknown | Debiopharm International SA | Completed, has results |
2011–2016 | Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants | Unknown | Debiopharm International SA | Completed, has results |
2016–2017 | Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV | Unknown | Gilead Sciences | Recruiting |
2015 | 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study | Â | Novartis Pharmaceuticals | Completed |
2014–2016 | Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities | Hanoi | National Development and Research Institutes, Inc. | Completed |